| JNPMEDI Launches United Organization to Strengthen End-to-End Capabilities
| Key Personnel Deployed in Various Departments, Including Medical and Legal Expert Jaehyun Lee (COS) and Digital Medical Device Clinical Expert Seungmi Lee
| "As a Life Science RDC Company, We will grow alongside our clients and contribute to industry revitalization through high expertise"
▲ Starting from the top left and moving clockwise: Business Division Hanyoung Oh (PL), SeongEun Park (PL), MinSoo Park (Director), HyeongJun Kim (Director), JunHyuk Lim (PL), SeungGeun Song (PL), YooJin Choi (PL), Development Division DaeGeon Kwon (Team Leader), CEO Office JaeHyun Lee (Head), Development Division MinJeong Kim (Product Team Leader), Business Division JooEun Kim (PL), Development Division JeongEun Kim (PO), Business Division SeungMi Lee (Executive Vice President), YeongYong Park (Head of Development Division, CTO), MinSeok Kim (Head of Business Division, CBO), Business Division JinGon Kim (Executive Vice President), SinAe Lee (PL), HoYoung Kang (PL).
JNPMEDI is focusing its organizational capabilities to enhance its competitiveness as a life sciences RDC company.
JNPMEDI, a medical data platform company, announced on May 16 that it has established a new 'RDC (Research, Development, and Commercialization) Team,' a collective of top experts in the pharmaceutical and biotech commercialization fields.
The RDC Team, an organization under the CEO, aims to prioritize client success. It provides comprehensive support at every stage of the pharmaceutical and medical device business, from business planning and investment connections to clinical trial operations, product commercialization, and post-market management.
To maximize its end-to-end service capabilities, JNPMEDI has brought together leading talents across all key business areas to form the RDC Team. Currently, JNPMEDI operates its total digital medical business boosting solution, based on its clinical operations and data management solution, Maven Clinical Cloud. This solution offers on-demand services for all business stages, from strategy and product development to clinical research, regulatory approval, and licensing.
The RDC Team includes many of JNPMEDI's top internal experts, such as doctors, pharmacists, and nurses. Key personnel from the CEO Office, Business Division (GBP), Development Division (CXD), and External Cooperation Division (Medical Affairs Group) are part of the new team.
Jaehyun Lee, head of the CEO Office, has comprehensively supported clients’ global expansion, legal strategies, and medical risk management. As a dentist and former lawyer from Kim & Chang, he aims to resolve clients' pain points using his expertise in the medical and legal fields.
The Business Division's core members also joined the new team to strengthen its capabilities. Recently recruited digital medical device clinical trial expert Seungmi Lee, along with Senior Manager Jingon Kim, who has over 15 years of industry experience, Director Hyungjun Kim, who has APAC sales experience, and Director Minsu Park, an AI and digital therapeutics expert, will handle solution sales and consulting, serving on the front lines of client management.
The Development Division's talents, led by CTO Youngyong Park, play a central role in accelerating digital transformation. Together with team leader Daegun Kwon, who has over 16 years of development experience, and product team leader Minjung Kim, an expert in digital product development, they oversee software development and maintenance related to Maven Clinical Cloud and provide timely innovative technology initiatives, including AI.
CEO Kwunho Jung stated, "By continuously recruiting experienced experts and focusing on strengthening organizational capabilities, we have launched a professional team that can provide top-level services across all areas. By securing key human resources, we have evolved into a life science RDC company capable of designing and providing customized solutions for all aspects of the pharmaceutical and biotech business. We aim to achieve mutual growth with our clients and contribute to industry revitalization through high expertise."
Recently, JNPMEDI has been actively diversifying its business, leveraging its clinical trial data management platform and global network to supply new growth engines to the pharmaceutical and biotech market. The company also launched the 'Total Digital Medical Business Boosting Solution,' providing comprehensive consulting services for pharmaceutical and medical device commercialization. Additionally, it has begun supporting biotech and medical device companies through direct investments and investor matching programs.
| JNPMEDI Launches United Organization to Strengthen End-to-End Capabilities
| Key Personnel Deployed in Various Departments, Including Medical and Legal Expert Jaehyun Lee (COS) and Digital Medical Device Clinical Expert Seungmi Lee
| "As a Life Science RDC Company, We will grow alongside our clients and contribute to industry revitalization through high expertise"
▲ Starting from the top left and moving clockwise: Business Division Hanyoung Oh (PL), SeongEun Park (PL), MinSoo Park (Director), HyeongJun Kim (Director), JunHyuk Lim (PL), SeungGeun Song (PL), YooJin Choi (PL), Development Division DaeGeon Kwon (Team Leader), CEO Office JaeHyun Lee (Head), Development Division MinJeong Kim (Product Team Leader), Business Division JooEun Kim (PL), Development Division JeongEun Kim (PO), Business Division SeungMi Lee (Executive Vice President), YeongYong Park (Head of Development Division, CTO), MinSeok Kim (Head of Business Division, CBO), Business Division JinGon Kim (Executive Vice President), SinAe Lee (PL), HoYoung Kang (PL).
JNPMEDI is focusing its organizational capabilities to enhance its competitiveness as a life sciences RDC company.
JNPMEDI, a medical data platform company, announced on May 16 that it has established a new 'RDC (Research, Development, and Commercialization) Team,' a collective of top experts in the pharmaceutical and biotech commercialization fields.
The RDC Team, an organization under the CEO, aims to prioritize client success. It provides comprehensive support at every stage of the pharmaceutical and medical device business, from business planning and investment connections to clinical trial operations, product commercialization, and post-market management.
To maximize its end-to-end service capabilities, JNPMEDI has brought together leading talents across all key business areas to form the RDC Team. Currently, JNPMEDI operates its total digital medical business boosting solution, based on its clinical operations and data management solution, Maven Clinical Cloud. This solution offers on-demand services for all business stages, from strategy and product development to clinical research, regulatory approval, and licensing.
The RDC Team includes many of JNPMEDI's top internal experts, such as doctors, pharmacists, and nurses. Key personnel from the CEO Office, Business Division (GBP), Development Division (CXD), and External Cooperation Division (Medical Affairs Group) are part of the new team.
Jaehyun Lee, head of the CEO Office, has comprehensively supported clients’ global expansion, legal strategies, and medical risk management. As a dentist and former lawyer from Kim & Chang, he aims to resolve clients' pain points using his expertise in the medical and legal fields.
The Business Division's core members also joined the new team to strengthen its capabilities. Recently recruited digital medical device clinical trial expert Seungmi Lee, along with Senior Manager Jingon Kim, who has over 15 years of industry experience, Director Hyungjun Kim, who has APAC sales experience, and Director Minsu Park, an AI and digital therapeutics expert, will handle solution sales and consulting, serving on the front lines of client management.
The Development Division's talents, led by CTO Youngyong Park, play a central role in accelerating digital transformation. Together with team leader Daegun Kwon, who has over 16 years of development experience, and product team leader Minjung Kim, an expert in digital product development, they oversee software development and maintenance related to Maven Clinical Cloud and provide timely innovative technology initiatives, including AI.
CEO Kwunho Jung stated, "By continuously recruiting experienced experts and focusing on strengthening organizational capabilities, we have launched a professional team that can provide top-level services across all areas. By securing key human resources, we have evolved into a life science RDC company capable of designing and providing customized solutions for all aspects of the pharmaceutical and biotech business. We aim to achieve mutual growth with our clients and contribute to industry revitalization through high expertise."
Recently, JNPMEDI has been actively diversifying its business, leveraging its clinical trial data management platform and global network to supply new growth engines to the pharmaceutical and biotech market. The company also launched the 'Total Digital Medical Business Boosting Solution,' providing comprehensive consulting services for pharmaceutical and medical device commercialization. Additionally, it has begun supporting biotech and medical device companies through direct investments and investor matching programs.